To Stent or Not to Stent: Is It a Question? Routine Trans‐Cystic Stenting Does Not Reduce Biliary Anastomotic Strictures Post‐Liver Transplantation
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.70224 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Marcos Vinicius Perini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery (Austin Precinct), The University of Melbourne, Heidelberg, Australia. Hauptthemen laut MEDLINE: Liver Transplantation, Stents, Postoperative Complications, Cholestasis. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
We aim to compare the incidence and risk factors for biliary anastomotic stricture (BAS) in patients undergoing orthotopic liver transplant (OLT) with and without transcystic externalised trans‐anastomotic biliary stenting.
Methods
A retrospective analysis was performed of a prospective database focused on 836 cadaveric OLT. Primary outcome measures were the incidence of BAS and risk factors related to its development.
Results
Duct‐to‐duct anastomosis was the most commonly performed biliary reconstruction (90.5%). Transcystic externalised trans‐anastomotic biliary stenting was performed in 420 patients (62.0%), being mostly used in patients having a duct‐to‐duct anastomosis (63.6%). BAS was seen in 222 (32.8%) patients, with a median time to diagnosis of 145.5 days ( IQR 50.3–370.5). BAS was higher in patients with a duct‐to‐duct reconstruction when compared to those having a bilio‐enteric reconstruction (34.3% vs. 18.7%, p = 0.02). The prevalence of BAS was not significantly different between patients who were stented and those who were not (34.5% vs. 30.0% respectively, p = 0.25). Multivariable analysis showed that older donor age, transplants performed earlier in the study period, higher MELD score, and type of biliary reconstruction (duct‐to‐duct) were independently associated with a higher risk of BAS .
Conclusion
Transcystic externalised biliary anastomotic stenting is not associated with a reduced biliary stricture incidence in OLT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery (Austin Precinct), The University of Melbourne, Heidelberg, Australia.
- HPB & Liver Transplant Surgery Unit, Austin Health, Heidelberg, Australia.
- Victorian Liver & Intestinal Transplant Unit, Austin Health, Heidelberg, Australia.
- The University of Melbourne, Melbourne School of Population and Global Health, Carlton, Australia.
ORCID-Profile: Bartholomew McKay
Zitieren
APA
Perini, M. V., Lee, E., Fink, M., Starkey, G., Yoshino, O., McKay, B., Furtado, R., Makalic, E., & Jones, R. (2025). To Stent or Not to Stent: Is It a Question? Routine Trans‐Cystic Stenting Does Not Reduce Biliary Anastomotic Strictures Post‐Liver Transplantation. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70224
Vancouver
Perini MV, Lee E, Fink M, Starkey G, Yoshino O, McKay B, et al. To Stent or Not to Stent: Is It a Question? Routine Trans‐Cystic Stenting Does Not Reduce Biliary Anastomotic Strictures Post‐Liver Transplantation. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70224
BibTeX
@article{Perini2025,
author = {Perini, Marcos Vinicius and Lee, Eunice and Fink, Michael and Starkey, Graham and Yoshino, Osamu and McKay, Bartholomew and Furtado, Ruelan and Makalic, Enes and Jones, Robert},
title = {To Stent or Not to Stent: Is It a Question? Routine Trans‐Cystic Stenting Does Not Reduce Biliary Anastomotic Strictures Post‐Liver Transplantation},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.70224}
}
EUVIMED